Two Sigma Securities’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Two Sigma Securities’s Portfolio AYLA Stock Details AYLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,063	Closed	-$6.43K	–	3501
2022 Q4	$6.43K	Sell	16,063 -5,163	-24%	-$3.35K	﹤0.01%	2429
2022 Q3	$21K	Buy	+21,226	New	+$28.6K	﹤0.01%	2294

Two Sigma Securities's AYLA Position: Q1 2023 in Review

Two Sigma Securities sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q1 2023, closing a stake of 16,063 shares — an estimated $6.43K sold.

Two Sigma Securities first reported a position in AYLA in Q3 2022 and held it in 2 quarters. The position peaked at $21K in Q3 2022. 0 funds tracked by Wall St. Rank hold AYLA as of Q1 2023.

Two Sigma Securities reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Two Sigma Securities sold 16,063 Ayala Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $6.43K.
Two Sigma Securities first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
Two Sigma Securities's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $21K in Q3 2022.
0 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Two Sigma Securities's 13F filing for Q1 2023, filed 15 May 2023.